Single Patient

for Pharmaceutical Companies

Expanded Access for Individual Patients

Each and every request received by a pharmaceutical or biopharmaceutical company pulls resources out of the daily work of drug development.  Even a single request, appearing manageable, can detract many of your resources to resolve and manage the request.

We have first hand knowledge of what your clinical and operations team members go through, being pulled away from their 'day job' at the expense of continuing your drug development responsibilities.  Drug development programs can't wait.  Let us manage these requests for your company using our experts and our proprietary turn-key technology platform Early Access System™.

EAC provides the expertise,  resources and technology to manage each and every individual Expanded Access / Compassionate Use request.

To hear more about our solutions, contact us.